Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02997345 · ClinicalTrials.gov registry record

PPROM Registry (Preterm Premature Rupture of Membranes)

A clinical trial of Premature Birth and Oligohydramnios, sponsored by American Alliance for pProm Support.

Recruiting
Registry status
3,000
Enrollment target
1
Study location

NCT02997345 is a study of Premature Birth and Oligohydramnios that is actively recruiting participants, run by American Alliance for pProm Support. The registered enrollment target is 3,000 participants, above the 315-participant average among 38 other Premature Birth trials with a reported enrollment target (852% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02997345, a study of Premature Birth and Oligohydramnios, is actively recruiting participants, sponsored by American Alliance for pProm Support.

RECRUITING
Registry status
3,000 participants
Enrollment target
1
Study location

Study Summary

Preterm Premature Rupture of Membranes (PPROM) before 37 weeks of pregnancy is responsible for 40% of preterm births in the United States. The PPROM Registry aims to identify possible causes of PPROM, evaluate trends in expectant management, measure maternal and fetal care, and to review short term and long term outcomes of affected pregnancies and births.

Interventions

  • OTHER There is no intervention associated with this study.

Study Locations (1)

Colorado

  • Www.Aapprom.Org/the-Registry - Denver

Trial Details

FieldValue
Enrollment Target 3,000 participants
Start Date 2013-07
Est. Completion 2030-12

What the Registry Record Tells You About NCT02997345

The ClinicalTrials.gov registry entry for NCT02997345 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 315-participant average among 38 other Premature Birth trials with a reported enrollment target (852% higher). The listed sponsor is American Alliance for pProm Support, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Premature Birth appearing as the primary indexed condition, and to 1 intervention - of which There is no intervention associated with this study. is the first listed.

NCT02997345 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT02997345 about?

NCT02997345 is a clinical study titled "PPROM Registry (Preterm Premature Rupture of Membranes)". Preterm Premature Rupture of Membranes (PPROM) before 37 weeks of pregnancy is responsible for 40% of preterm births in the United States. The PPROM Registry aims to identify possible causes of PPROM, evaluate trends in expectant management, measure maternal and fetal care, and to review short term ...

What is the current status of trial NCT02997345?

This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2013-07. Estimated completion is 2030-12.

What conditions does trial NCT02997345 study?

This clinical trial studies the following conditions: Premature Birth, Oligohydramnios, Fetal Membranes, Premature Rupture, Preterm Premature Rupture of the Membranes.

What interventions are being tested in trial NCT02997345?

The interventions under investigation include: There is no intervention associated with this study. (OTHER).

Who is sponsoring clinical trial NCT02997345?

This trial is sponsored by American Alliance for pProm Support, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02997345 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Premature Birth

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.